|
Q2 FY2027
As of Jul 4, 2026
|
Q1 FY2027
As of Apr 4, 2026
|
Q4 FY2026
As of Jan 3, 2026
|
Q3 FY2026
As of Sep 27, 2025
|
Q2 FY2026
As of Jun 28, 2025
|
Q1 FY2026
As of Mar 29, 2025
|
Q4 FY2025
As of Dec 28, 2024
|
Q3 FY2025
As of Sep 28, 2024
|
Q2 FY2025
As of Jun 29, 2024
|
Q1 FY2025
As of Mar 30, 2024
|
Q4 FY2024
As of Dec 30, 2023
|
Q3 FY2024
As of Sep 30, 2023
|
Q2 FY2024
As of Jul 1, 2023
|
Q1 FY2024
As of Apr 1, 2023
|
Q4 FY2023
As of Dec 31, 2022
|
Q3 FY2023
As of Oct 1, 2022
|
Q2 FY2023
As of Jul 2, 2022
|
Q1 FY2023
As of Apr 2, 2022
|
Q4 FY2022
As of Jan 1, 2022
|
Q3 FY2022
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Receivable from related party | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Payable to related party | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Convertible note payable, current | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Accrued warranty | ||||||||||||||||||||
| Deferred revenue, current | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| PPP loan | ||||||||||||||||||||
| Accrued warranty | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Convertible note payable | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 2,000,000 shares authorized, no shares issued and outstanding | ||||||||||||||||||||
| Preferred stock, $0.01 par value Authorized: 2,000,000 shares; Issued and outstanding: 600,000 shares of Series B convertible preferred stock as of both July 4, 2026 and January 3, 2026 (liquidation preference of $6.0 million as of both July 4, 2026 and January 3, 2026) | ||||||||||||||||||||
| Common stock, $0.01 par value: Authorized: 63,500,000 shares; Issued and outstanding 17,452,915 shares as of July 4, 2026 and 17,306,521 as of January 3, 2026 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
